288 related articles for article (PubMed ID: 7389204)
1. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
[TBL] [Abstract][Full Text] [Related]
2. Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation.
Mortensen RF; Beisel K; Zeleznik NJ; Le PT
J Immunol; 1983 Feb; 130(2):885-9. PubMed ID: 6600258
[TBL] [Abstract][Full Text] [Related]
3. Complement-independence of the acute-phase production of serum amyloijd P-component (SAP) in mice.
Pepys MB; Rogers SL
Br J Exp Pathol; 1980 Apr; 61(2):156-9. PubMed ID: 7000131
[TBL] [Abstract][Full Text] [Related]
4. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB
Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
[TBL] [Abstract][Full Text] [Related]
5. Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. I. The acute phase proteins, C3 and serum amyloid P-component (SAP).
Pepys MB; Baltz ML; Musallam R; Doenhoff MJ
Immunology; 1980 Feb; 39(2):249-54. PubMed ID: 6966607
[TBL] [Abstract][Full Text] [Related]
6. Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation.
Zahedi K; Whitehead AS
J Immunol; 1989 Nov; 143(9):2880-6. PubMed ID: 2809211
[TBL] [Abstract][Full Text] [Related]
7. Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins.
Mortensen RF; Shapiro J; Lin BF; Douches S; Neta R
J Immunol; 1988 Apr; 140(7):2260-6. PubMed ID: 2450915
[TBL] [Abstract][Full Text] [Related]
8. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
[TBL] [Abstract][Full Text] [Related]
9. Casein-induced experimental amyloidosis. VI. A pathogenic role for b cells in the murine model.
Scheinberg MA; Cathcart ES
Immunology; 1976 Sep; 31(3):443-53. PubMed ID: 800407
[TBL] [Abstract][Full Text] [Related]
10. Amyloid resistance in A/J mice. Studies with a transfer model.
Wohlgethan JR; Cathcart ES
Lab Invest; 1980 Jun; 42(6):663-7. PubMed ID: 7392571
[TBL] [Abstract][Full Text] [Related]
11. Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy.
Murakami T; Yi S; Maeda S; Tashiro F; Yamamura K; Takahashi K; Shimada K; Araki S
Am J Pathol; 1992 Aug; 141(2):451-6. PubMed ID: 1497094
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis.
Benson MD; Scheinberg MA; Shirahama T; Cathcart ES; Skinner M
J Clin Invest; 1977 Mar; 59(3):412-7. PubMed ID: 838858
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.
de Beer FC; Baltz ML; Munn EA; Feinstein A; Taylor J; Bruton C; Clamp JR; Pepys MB
Immunology; 1982 Jan; 45(1):55-70. PubMed ID: 7056568
[TBL] [Abstract][Full Text] [Related]
14. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury.
Cho K; Pham TN; Crivello SD; Jeong J; Green TL; Greenhalgh DG
Shock; 2004 Feb; 21(2):144-50. PubMed ID: 14752288
[TBL] [Abstract][Full Text] [Related]
15. Experimental amyloidosis in the hamster: correlation between hamster female protein levels and amyloid deposition.
Snel FW; Niewold TA; Baltz ML; Hol PR; Van Ederen AM; Pepys MB; Gruys E
Clin Exp Immunol; 1989 May; 76(2):296-300. PubMed ID: 2474395
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy.
Kisilevsky R; Boudreau L; Foster D
Lab Invest; 1983 Jan; 48(1):60-7. PubMed ID: 6823092
[TBL] [Abstract][Full Text] [Related]
17. Casein-induced experimental amyloidosis. IX. Alterations in marrow dependent function.
Yonkosky D; Kumar V; Cathcart ES; Bennett M
Immunology; 1978 Jul; 35(1):133-9. PubMed ID: 355124
[TBL] [Abstract][Full Text] [Related]
18. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
[TBL] [Abstract][Full Text] [Related]
19. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
Gonnerman WA; Kandel R; Cathcart ES
Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
[TBL] [Abstract][Full Text] [Related]
20. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
